Executive Compensation AGREEMENTExecutive Compensation Agreement • March 13th, 2015 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products • Nevada
Contract Type FiledMarch 13th, 2015 Company Industry JurisdictionThis Executive Compensation Agreement (“Agreement”) is entered into as of March 10, 2015, effective as of January 1, 2015 (“Commencement Date”), by and between PharmaCyte Biotech, Inc. a Nevada corporation (together with its successors and assigns, “Company”), and Kenneth L. Waggoner (“Executive”). The Company and the Executive are each referred to in this Agreement as a “Party” and collectively as “Parties.”
FIRST stock option agreementFirst Stock Option Agreement • March 13th, 2015 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products • Nevada
Contract Type FiledMarch 13th, 2015 Company Industry JurisdictionThis First Stock Option Agreement (“Agreement”) is made as of the 10th day of March, 2015 (“Effective Date”) between PharmaCyte Biotech, Inc. (“Company”) and Gerald W. Crabtree (“Participant”).
SECOND stock option agreementSecond Stock Option Agreement • March 13th, 2015 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products • Nevada
Contract Type FiledMarch 13th, 2015 Company Industry JurisdictionThis Second Stock Option Agreement (“Agreement”) is made as of the 10th day of March, 2015 (“Effective Date”) between PharmaCyte Biotech, Inc. (“Company”) and Kenneth L. Waggoner (“Participant”).